Company intelligence / Profile preview

CIAN Diagnostics

Gaithersburg, Maryland, United States

Ownership: Private
Employees: ~62
Development stage: Other

Overview

CIAN Diagnostics is a full-spectrum, CLIA- and CAP-accredited diagnostic laboratory specializing in high-throughput COVID-19, molecular/genetic, and toxicology testing; active in both public health and clinical research settings, it has performed over 3 million COVID-19 tests and is a key partner for government agencies, schools, and research organizations.[1][2][3][4]

Therapeutic areas: Infectious DiseasesRare DiseasesOther
Industry: Molecular Diagnostics

Partnerships

EMINENT Services Corporation (joint venture: EMINENT Life Sciences)National Institutes of Health (NIH)Takeda Pharmaceutical CompanyEmmes Clinical ServicesYale UniversityMaryland Department of HealthNational Institute of Allergy and Infectious Diseases (NIAID)

Beyond the preview

Go deeper on CIAN Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CIAN Diagnostics.

Explore the full profile